Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Uncategorized

Sysco Shares Move Lower; Hearing Co Currently Having Conference Call

http://goz3.com/SyscoInvestorDay2021/

byBenzinga Newsdesk

May 20, 2021

1 minute read

http://goz3.com/SyscoInvestorDay2021/

Is Netflix’s Stock Overvalued Or Undervalued?

By Wayne Duggan

November 2, 1:21 PM

Netflix (NASDAQ: NFLX) shares have outperformed the S&P 500 in 2021, generating a year-to-date total return of 25.9%. But after gaining 114.6% in the past three years, investors may be wondering if there’s any value left in Netflix stock.

NFLX

Morgan Stanley Maintains Equal-Weight on Newell Brands, Lowers Price Target to $27

By Benzinga Newsdesk

August 2, 10:05 AM

Morgan Stanley analyst Dara Mohsenian maintains Newell Brands (NASDAQ:NWL) with a Equal-Weight and lowers the price target from $29 to $27.

NWL

REV Group Q3 EPS $0.36 Beats $0.34 Estimate, Sales $593.30M Miss $663.40M Estimate

By Benzinga Newsdesk

September 8, 7:14 AM

REV Group (NYSE:REVG) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.34 by 5.88 percent. This is a 260 percent increase over earnings of $0.10 per share from the same

REVG

eFFECTOR Therapeutics Q3 EPS $0.42 Up From $(5.29) YoY, Sales $427.00K Down From $574.00K YoY

By Benzinga Newsdesk

November 8, 8:07 AM

eFFECTOR Therapeutics (NASDAQ:EFTR) reported quarterly earnings of $0.42 per share. This is a 107.94 percent increase over losses of $(5.29) per share from the same period last year. The company reported $427.00

EFTR

Sysco Shares Move Lower; Hearing Co Currently Having Conference Call

Related Posts

Is Netflix’s Stock Overvalued Or Undervalued?

Morgan Stanley Maintains Equal-Weight on Newell Brands, Lowers Price Target to $27

REV Group Q3 EPS $0.36 Beats $0.34 Estimate, Sales $593.30M Miss $663.40M Estimate

eFFECTOR Therapeutics Q3 EPS $0.42 Up From $(5.29) YoY, Sales $427.00K Down From $574.00K YoY